Full-Time

Beauty Sales Consultant

Licensed

Posted on 7/9/2026

Deadline 9/10/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$19 - $28/hr

Company Historically Provides H1B Sponsorship

Albany, NY, USA

In Person

On-site location at CVS Albany facility (ZIP 02432).

Category
Sales & Account Management (1)
Required Skills
Sales
Customer Service

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • Must possess a current and valid Cosmetology/Esthetician License in the state in which you will be working.
  • Must maintain an active Cosmetology/Esthetician license at all times in the state you are employed and ensure it is present and displayed during working hours at your work site(s) as mandated by that state.
  • CVS Licensed Beauty Sales Consultants must demonstrate the ability and willingness to perform ear-piercing services in all stores. Licensed Beauty Sales Consultants are also required to perform all other services offered in any location in which they work.
  • Must pass all required skills assessments and training courses to fully execute paid service options offered in the store locations in which you work.
  • Ability to use sales data with product/brand knowledge to meet sales and beauty service goals
  • Strong interpersonal, organizational and communication skills.
  • Goal-driven, with an ability to multi-task.
  • Ability to work independently and as an integral part of a team in a fast-paced environment, handling multiple priorities and quickly learning new procedures.
  • Available to work at a CVS store and travel to sales programs and events as needed.
  • Available to work a flexible retail schedule, which may include mornings, evenings, weekends, extended hours and “Peak” Hours
  • Nevada Licensed Beauty Sales Consultant applicants must provide confirmation of a MAKEUP ARTIST REGISTRATION/ THREADER REGISTRATION issued from the state of Nevada.
  • In specific CVS stores, we require bi-lingual beauty advisors that can speak to customers in both English and Spanish.
  • Must be at least 18 years old.
  • High school diploma or equivalent.
Responsibilities
  • Seek out customers to ensure they have a world class beauty advisor experience.
  • Provide personalized sales service based on customer needs, productive upselling and suggestive selling.
  • Maneuver in a conversation to stimulate a different thought process. This means you are confident and comfortable using your verbal skills to generate sales.
  • Be the brand expert by answering customer questions in detail with product knowledge to produce the largest sales basket possible.
  • Engage all customers with CVS services, Beauty Club programs and invite customers to in-store events and/or explain current promotions to close the sale of products and services.
  • Represent both the CVS and partner brands when interacting with customers and uphold the highest standards of service.
  • CVS Licensed Beauty Sales Consultants are required to provide ear-piercing services in all stores. Licensed Beauty Sales Consultants are also required to perform all other applicable services offered in any location in which they work.
  • CVS Licensed Beauty Sales Consultants must successfully pass assessments of proficiency before performing services in store.
  • Educate beauty customers by demonstrating proper product usage and highlighting product features and benefits to help drive purchase conversion.
  • Manage time effectively between consultations, scheduled services and walk-in clients.
  • Display current and active Cosmetology/Esthetician license during all working hours in all locations in which they work as mandated by the state.
Desired Qualifications
  • Prior beauty sales experience with a strong passion for beauty.
  • High school diploma or equivalent preferred but not required

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 Q2 revenue hit $106.1 billion, and adjusted EPS reached $2.58.
  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 and cash flow to $11.5 billion.
  • July 14, 2026 FTC settlement removed PBM litigation over rebates and network contracting.

What critics are saying

  • 340B lawsuits from Mount Sinai, Michigan, and Kansas seek hundreds of millions from CVS.
  • Pharmacy revenue depends on Rite Aid gains normalizing after 2025 bankruptcy acquisitions.
  • CVS carries $175 billion liabilities; PBM regulation could break the integration thesis by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies into one consumer funnel.
  • August 5, 2026 Eli Lilly deal puts Zepbound pricing inside CVS Health app.
  • CVS's $20 billion AI program unifies claims, pharmacy, and care workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.

PR Newswire
Aug 5th, 2026
CVS Health posts $106.1B Q2 revenue, raises full-year earnings guidance to $7.90-$8.10

CVS Health reported second quarter 2026 revenues of $106.1 billion, up 7.3% year-over-year. The company posted GAAP diluted earnings per share of $2.31 and adjusted EPS of $2.58, compared to $0.80 and $1.81 respectively in the prior year. The company raised its full-year 2026 guidance, increasing GAAP diluted EPS guidance to $6.84-$7.04 from $6.24-$6.44 and adjusted EPS guidance to $7.90-$8.10 from $7.30-$7.50. Cash flow from operations guidance was raised to at least $11.5 billion from at least $9.5 billion. CVS Health generated $10.6 billion in year-to-date cash flow from operations. The improved performance was primarily driven by the Health Care Benefits segment, reflecting continued execution on its margin recovery plan. The company operates approximately 9,000 retail pharmacy locations and serves around 87 million plan members through its pharmacy benefits manager.

INACTIVE